198 related articles for article (PubMed ID: 32648077)
1. Effect of memantine on expression of Bace1-as and Bace1 genes in STZ-induced Alzheimeric rats.
Azadfar P; Noormohammadi Z; Noroozian M; Eidi A; Mortazavi P
Mol Biol Rep; 2020 Aug; 47(8):5737-5745. PubMed ID: 32648077
[TBL] [Abstract][Full Text] [Related]
2. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis.
Zhao MY; Wang GQ; Wang NN; Yu QY; Liu RL; Shi WQ
Neurol Res; 2019 Jun; 41(6):489-497. PubMed ID: 31014193
[TBL] [Abstract][Full Text] [Related]
3. Combination strategy employing BACE1 inhibitor and memantine to boost cognitive benefits in Alzheimer's disease therapy.
Tarif AMM; Huhe H; Ohno M
Psychopharmacology (Berl); 2024 May; 241(5):975-986. PubMed ID: 38197930
[TBL] [Abstract][Full Text] [Related]
4. A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease.
Fukumoto H; Takahashi H; Tarui N; Matsui J; Tomita T; Hirode M; Sagayama M; Maeda R; Kawamoto M; Hirai K; Terauchi J; Sakura Y; Kakihana M; Kato K; Iwatsubo T; Miyamoto M
J Neurosci; 2010 Aug; 30(33):11157-66. PubMed ID: 20720123
[TBL] [Abstract][Full Text] [Related]
5. BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.
Yu CJ; Liu W; Chen HY; Wang L; Zhang ZR
Cell Biochem Funct; 2014 Oct; 32(7):590-6. PubMed ID: 25230339
[TBL] [Abstract][Full Text] [Related]
6. [Effect of hyperforin on learning and memory abilities and Aβ₁₋₄₂, βAPP and BACE1 protein expressions in hippocampus of Alzheimer's disease model mice].
Geng YN; Wu YJ; Zhang WX
Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(15):2877-2882. PubMed ID: 28914032
[TBL] [Abstract][Full Text] [Related]
7. Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.
Huang HC; Zheng BW; Guo Y; Zhao J; Zhao JY; Ma XW; Jiang ZF
J Alzheimers Dis; 2016 Apr; 52(3):899-911. PubMed ID: 27060945
[TBL] [Abstract][Full Text] [Related]
8. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
10. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
Mao P; Manczak M; Calkins MJ; Truong Q; Reddy TP; Reddy AP; Shirendeb U; Lo HH; Rabinovitch PS; Reddy PH
Hum Mol Genet; 2012 Jul; 21(13):2973-90. PubMed ID: 22492996
[TBL] [Abstract][Full Text] [Related]
12. [Effects of huannao yicong recipe extract on the learning and memory and related factors of Abeta generation in the brain of APP transgenic mice].
Li H; Liu MF; Liu JG; Liu LT; Guan J; Cai LL; Hu J; Wei Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jan; 33(1):90-4. PubMed ID: 23596795
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease.
Zhiyou C; Yong Y; Shanquan S; Jun Z; Liangguo H; Ling Y; Jieying L
Neurochem Res; 2009 Jul; 34(7):1226-35. PubMed ID: 19123057
[TBL] [Abstract][Full Text] [Related]
14. BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer's disease mouse model.
Shi Z; Hong Y; Zhang K; Wang J; Zheng L; Zhang Z; Hu Z; Han X; Han Y; Chen T; Yao Q; Cui H; Hong W
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2398-2407. PubMed ID: 28502705
[TBL] [Abstract][Full Text] [Related]
15. BACE1-AS prevents BACE1 mRNA degradation through the sequestration of BACE1-targeting miRNAs.
Zeng T; Ni H; Yu Y; Zhang M; Wu M; Wang Q; Wang L; Xu S; Xu Z; Xu C; Xiong J; Jiang J; Luo Y; Wang Y; Liu H
J Chem Neuroanat; 2019 Jul; 98():87-96. PubMed ID: 30959172
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of fibroblast growth factor-2 (FGF2) reduces BACE1 expression and amyloid pathology in APP23 mice.
Katsouri L; Ashraf A; Birch AM; Lee KK; Mirzaei N; Sastre M
Neurobiol Aging; 2015 Feb; 36(2):821-31. PubMed ID: 25457554
[TBL] [Abstract][Full Text] [Related]
17. Ethanol Alters APP Processing and Aggravates Alzheimer-Associated Phenotypes.
Huang D; Yu M; Yang S; Lou D; Zhou W; Zheng L; Wang Z; Cai F; Zhou W; Li T; Song W
Mol Neurobiol; 2018 Jun; 55(6):5006-5018. PubMed ID: 28799137
[TBL] [Abstract][Full Text] [Related]
18. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
Devi L; Ohno M
Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882
[TBL] [Abstract][Full Text] [Related]
19. Silencing of long noncoding RNA XIST attenuated Alzheimer's disease-related BACE1 alteration through miR-124.
Yue D; Guanqun G; Jingxin L; Sen S; Shuang L; Yan S; Minxue Z; Ping Y; Chong L; Zhuobo Z; Yafen W
Cell Biol Int; 2020 Feb; 44(2):630-636. PubMed ID: 31743528
[TBL] [Abstract][Full Text] [Related]
20. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.
Kimura R; Devi L; Ohno M
J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
